• Skip to main content
  • Skip to navigation
  • Accessibility
  • Contact Us
Government of Western Australia Crest
Government of Western Australia
Government of Western Australia Crest

Additional Menu

  • Accessibility
  • Contact us
Go to WA Government search
  • About us
    • Our Vision and Values
    • Strategic Plan
    • Our Team
      • Health Service Board
    • Customer Service
      • Provide Your Feedback
      • Customer Service Charter
      • Freedom of Information
      • Public Interest Disclosure
      • Quality Management
    • Work With Us
      • Vacancies
      • Pathways to Working With Us
      • Diversity and Inclusion
    • Research & Partnerships
    • Education
      • HLT37215 Certificate III in Pathology Collection
    • Annual Reports
    • Contact us
    • Locations
  • Our Services
    • Clinical Services
      • Anatomical Pathology
      • Biochemistry
      • Diagnostic Genomics
      • Forensic Services
      • Haematology & Blood Transfusion
      • Immunology
      • Microbiology
      • Point-of-Care Testing
    • Commercial Services
      • Food and Water Testing
      • Health & Workplace Testing
      • Media Manufacturing
      • Pharmaceutical Testing
      • Request a Quote
      • Resources
    • Perinatal Pathology
      • Information for Families
      • Information for Health Professionals
      • Information for Funeral Directors
    • PCH Mortuary
      • Information for Families
      • Information for Health Professionals
    • Clinical Trials and Research
    • State Mortuary Bereavement Centre
  • For Health Professionals
    • Service Updates
    • Test Directory and Resources
    • Requesting Pathology
    • Respiratory Pathogen Dashboard
    • Results
  • Electronic Results Delivery
  • For Patients
    • Find a Collection Centre
    • Infant and Child Tests
    • Preparing for Your Test
    • Measles
    • Mpox (monkeypox)
    • Pay a Bill
      • Hospital Inpatients
      • Medicare Rebates
    • Your Results
    • Your Safety
  • Latest News
  1. Home
  2. For Health Professionals
  3. Service Updates
  4. 2025
  5. 08
  6. 21
  7. Plasma Uracil for DPD Deficiency Screening

Plasma Uracil for DPD Deficiency Screening

Plasma Uracil for DPD Deficiency Screening

28/08/2025

PathWest is proud to introduce Plasma Uracil Testing

Plasma Uracil Testing

This test is designed to identify, prior to initiation of therapy, patients who are at increased risk of early, severe toxicity from fluoropyrimidine (FP) chemotherapy compounds, such as 5-Fluorouracil and capecitabine.
  • Patients with dihydropyrimidine dehydrogenase (DPD) deficiency have a reduced ability to metabolise FP drugs and are at increased risk of early, severe, and potentially life-threatening toxicity.
  • The risk of acute toxicity with FP therapy increases with the increasing uracil concentrations, associated with increasing risk of DPD deficiency.   

Important to note:

Eligibility

All patients scheduled to commence FP chemotherapy.

  • Testing should be done prior to treatment initiation.
  • Testing is only required once per patient.
  • If the opportunity to test prior to initiation is missed, please contact the department for advice.

Ordering Process

  • Restricted to Medical Oncology teams.
  • Not available via CPOE.
  • A specific request form must be used:
    • Hard copies have been distributed to Medical Oncology departments.
    • An electronic version is available here for printing and filling out.
  • Requesting clinicians must:
    • Complete all tick boxes in the Clinical Notes section.
    • Clearly record both the Medical Oncology consultant’s name and the requesting doctor’s name (abnormal results will be phoned directly to the consultant).

Rollout and Collection

  • Commencement Date: 1 September 2025
  • Collection Sites:
    • PathWest Fiona Stanley Hospital (FSH)
    • PathWest Sir Charles Gairdner Hospital (SCGH), E Block
    • Monday to Friday, before 3:00 PM
  • Private pathology collections are not accepted due to strict sample handling requirements.

Sample Handling

  • Strict pre-analytical protocols apply.
  • Delays in centrifugation or freezing may result in falsely elevated uracil levels.
  • All results will be reviewed by a Pathologist prior to reporting and Uracil results will not be reported in cases of suboptimal pre-analytical sample handling. In these instances, the requesting doctor will be notified directly to arrange contacting patient for urgent re-collection of plasma uracil, and completion of a new pathology request form.

Turnaround time
7 days 

Cost to patient
No out-of-pocket cost to patients. 

Contact Information


Sample collection, handling, or transport queries:
Ms Conchita Boyder
Scientist in charge, Special Chemistry,

PathWest Laboratory Medicine WA
📞 (08) 6383 4113


For queries regarding Plasma Uracil test interpretation:

Dr. Rhonda Maguire

Chemical Pathologist, Biochemistry, Clinical Pharmacology and Toxicology

PathWest Laboratory Medicine WA

📧: Rhonda.Maguire@health.wa.gov.au


 

Previous Next
Last Updated: 28/08/2025
  • Facebook
  • LinkedIn

Footer menu

  • wa.gov.au
  • Copyright
  • Disclaimer
  • Privacy
  • Sitemap
  • Contact Us

Brought to you by the Department of Health, Western Australia

© Government of Western Australia 2018 to